Mufg Americas Holdings Corp Regeneron Pharmaceuticals, Inc. Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$573.97 - $724.32 $293,872 - $370,851	-512 Reduced 60.81%	330 $227,000
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $293,872 - $370,851	-512 Reduced 60.81%	330 $227,000
Q2 2022 Dec 01, 2022	SELL	$548.35 - $738.84 $43,868 - $59,107	-80 Reduced 8.68%	842 $498,000
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $43,868 - $59,107	-80 Reduced 8.68%	842 $498,000
Q1 2022 Dec 01, 2022	SELL	$595.12 - $698.43 $38,087 - $44,699	-64 Reduced 6.49%	922 $644,000
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $38,087 - $44,699	-64 Reduced 6.49%	922 $644,000
Q4 2021 Dec 01, 2022	SELL	$543.48 - $670.97 $30,434 - $37,574	-56 Reduced 5.37%	986 $623,000
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $30,434 - $37,574	-56 Reduced 5.37%	986 $623,000
Q3 2021 Dec 01, 2022	SELL	$574.03 - $680.96 $142,359 - $168,878	-248 Reduced 19.22%	1,042 $631,000
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $142,359 - $168,878	-248 Reduced 19.22%	1,042 $631,000
Q2 2021 Dec 01, 2022	SELL	$472.8 - $558.54 $187,228 - $221,181	-396 Reduced 23.49%	1,290 $721,000
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $187,228 - $221,181	-396 Reduced 23.49%	1,290 $721,000
Q1 2021 Dec 01, 2022	SELL	$446.73 - $548.2 $614,700 - $754,323	-1,376 Reduced 44.94%	1,686 $798,000
Q1 2021 Apr 30, 2021	SELL	$446.73 - $548.2 $614,700 - $754,323	-1,376 Reduced 44.94%	1,686 $798,000
Q4 2020 Dec 01, 2022	SELL	$478.3 - $607.98 $1.14 Million - $1.45 Million	-2,393 Reduced 43.87%	3,062 $1.48 Million
Q4 2020 Feb 03, 2021	SELL	$478.3 - $607.98 $1.14 Million - $1.45 Million	-2,393 Reduced 43.87%	3,062 $1.48 Million
Q3 2020 Dec 01, 2022	SELL	$544.75 - $658.21 $264,203 - $319,231	-485 Reduced 8.16%	5,455 $3.05 Million
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $264,203 - $319,231	-485 Reduced 8.16%	5,455 $3.05 Million
Q2 2020 Dec 01, 2022	BUY	$493.32 - $643.92 $2.77 Million - $3.61 Million	5,610 Added 1700.0%	5,940 $3.71 Million
Q2 2020 Aug 06, 2020	SELL	$493.32 - $643.92 $3.01 Million - $3.92 Million	-6,094 Reduced 50.64%	5,940 $3.71 Million
Q1 2020 Apr 24, 2020	SELL	$336.18 - $494.43 $882,136 - $1.3 Million	-2,624 Reduced 17.9%	12,034 $5.88 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $130,760 - $179,595	477 Added 3.36%	14,658 $5.5 Million
Q3 2019 Nov 06, 2019	BUY	$273.46 - $318.39 $434,801 - $506,240	1,590 Added 12.63%	14,181 $3.93 Million
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $1 Million - $1.39 Million	3,344 Added 36.16%	12,591 $3.94 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $2.68 Million - $3.17 Million	7,202 Added 352.18%	9,247 $3.8 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $686,751 - $824,216	2,045 New	2,045 $763,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account